Wellington Management Group
LFCR icon

Wellington Management Group’s Lifecore Biomedical LFCR Stock Holding History

Wellington Management Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-82,700
Closed -$1M – 2197
2013
Q4 		$1M Sell
82,700
-2,618
-3% -$31.3K ﹤0.01% 1837
2013
Q3 		$1.04M Hold
85,318
– – ﹤0.01% 1788
2013
Q2 		$1.13M Buy
+85,318
New +$1.18M ﹤0.01% 1746

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group's LFCR Position: Q1 2014 in Review

Wellington Management Group sold out of Lifecore Biomedical (LFCR) in Q1 2014, closing a stake of 82,700 shares — an estimated $1M sold.

Wellington Management Group first reported a position in LFCR in Q2 2013 and held it in 3 quarters. The position peaked at $1.13M in Q2 2013. 98 funds tracked by Wall St. Rank hold LFCR as of Q1 2014.

  • Wellington Management Group reported no remaining Lifecore Biomedical position as of Q1 2014 after selling out during the quarter.
  • Wellington Management Group sold 82,700 Lifecore Biomedical shares in Q1 2014, an estimated $1M.
  • Wellington Management Group first reported a position in Lifecore Biomedical in Q2 2013 and held it in 3 quarters.
  • Wellington Management Group's Lifecore Biomedical position peaked at $1.13M in Q2 2013.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2014.

Based on Wellington Management Group's 13F filing for Q1 2014, filed 15 May 2014.